首页> 美国卫生研究院文献>RMD Open >Original article: Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis

【2h】

Original article: Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis

机译：原始文章：类风湿关节炎患者开始或逐渐减少抗TNF治疗后血清钙卫蛋白（S100A8 / A9）对临床反应的预测价值

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

ObjectivesCalprotectin (S100A8/A9) has been correlated with disease activity in rheumatoid arthritis (RA). The aim of this study was to investigate the predictive value of serum calprotectin for clinical response after starting and tapering anti-tumour necrosis factor treatment in RA.

机译：目的钙卫蛋白（S100A8 / A9）与类风湿关节炎（RA）的疾病活动性相关。这项研究的目的是调查血清钙卫蛋白对RA开始和逐渐减少抗肿瘤坏死因子治疗后的临床反应的预测价值。

著录项

期刊名称 RMD Open
作者
Lieke Tweehuysen; Nathan den Broeder; Noortje van Herwaarden; Leo A B Joosten; Peter L van Lent; Thomas Vogl; Frank H J van den Hoogen; Rogier M Thurlings; Alfons A den Broeder;
展开▼
作者单位

展开▼
年(卷),期 2018(4),1
年度 2018
页码 e000654
总页数 7
原文格式 PDF
正文语种
中图分类
关键词
rheumatoid arthritis biologic agents prediction of response tapering calprotectin biomarkers;

机译：类风湿关节炎;生物制剂;反应预测;渐减;钙卫蛋白;生物标志物;

相似文献

外文文献
中文文献
专利

1. Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis [J] . Hilde Haugedal Nordal, Karl Albert Brokstad, Magne Solheim, Arthritis research & therapy. . 2017,第1期

机译：钙卫蛋白（S100A8 / A9）与超声检测到的滑膜炎联系最紧密，并预测对生物治疗的反应：对已确诊的类风湿关节炎患者进行的纵向研究结果
2. A single nucleotide polymorphism of TRAF1 predicts the clinical response to anti-TNF treatment in Japanese patients with rheumatoid arthritis [J] . Nishimoto T., Seta N., Anan R., Clinical and experimental rheumatology . 2014,第2期

机译：TRAF1的单核苷酸多态性预测日本类风湿关节炎患者对抗TNF治疗的临床反应
3. Serum interleukin-6 and survivin levels predict clinical response to etanercept treatment in patients with established rheumatoid arthritis [J] . Shi Rui, Chen Muzhi, Litifu Bahaerguli, Modern rheumatology . 2018,第1期

机译：血清白细胞介素-6和Survivin水平预测成熟类风湿性关节炎患者对Etanercept治疗的临床反应
4. Deep radiomic prediction with clinical predictors of the survival in patients with rheumatoid arthritis-associated interstitial lung diseases [C] . Radin A. Nasirudin, Janne J. Nappi, Chinatsu Watari, SPIE Medical Imaging Conference . 2018

机译：类风湿关节炎相关性间质性肺疾病患者的深部放射学预测和生存期的临床预测
5. Clinical studies of immunomodulatory activities of Yunzhi -Danshen in breast cancer and nasopharyngeal carcinoma patients, and Lingzhi-San Miao San in rheumatoid arthritis patients. [D] . Bao, Yixi. 2005

机译：云芝丹参对乳腺癌和鼻咽癌患者及类风湿关节炎灵芝三妙散的免疫调节活性的临床研究。
6. Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis [O] . Hilde Haugedal Nordal, Karl Albert Brokstad, Magne Solheim, 2017

机译：钙卫蛋白（S100A8 / A9）与超声检测到的滑膜炎联系最紧密并预测对生物疗法的反应：对已确诊的类风湿关节炎患者进行的纵向研究结果
7. Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis [O] . 2017

机译：钙卫蛋白（S100A8 / A9）与超声检测到的滑膜炎联系最紧密，并预测对生物治疗的反应：对已确诊的类风湿关节炎患者进行的纵向研究结果

Original article: Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅